{"slug":"selank-nerve-damage","verification":{"valid":true,"entries":2,"head":"15adbe07115565d67e68ee05b7fa2185ca2ab6e09a351b6ac260e37645cee541"},"energy":{"passes":2,"tokens_in":18001,"tokens_out":2676,"tokens_total":20677,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"15adbe07115565d67e68ee05b7fa2185ca2ab6e09a351b6ac260e37645cee541"},"provenance":[{"ts":"2026-06-30T00:41:03.054Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Selank for Nerve Damage\nSlug: selank-nerve-damage\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"selank\",\"name\":\"Selank\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"selank\",\"name\":\"Selank\",\"section_title\":\"Why Selank might help you\",\"layer\":\"anxiety / neurochemistry\",\"steps\":[\"**What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\",\"**What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\",\"**Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.\\n2. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\\n3. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the ","response":"{\n  \"slug\": \"selank-nerve-damage\",\n  \"title\": \"Selank for Nerve Damage: Evidence-Graded Review\",\n  \"body\": \"## What's breaking down\\n\\nNerve damage involves layers of degeneration where repair pathways fall behind. Key issues include disrupted neurotransmission, reduced neurotrophic support like BDNF signaling, neuroinflammation, and secondary effects such as chronic stress chemistry that amplifies pain perception and impairs recovery. These create a cycle where mechanical or chemical stress on nerves outpaces cellular repair mechanisms.\\n\\n## Why Selank might help you\\n\\n1. **What keeps failing:** Chronic stress chemistry, impaired GABAergic signaling, and lowered BDNF-related repair in neural tissue after damage.\\n2. **What Selank is studied to do:** Studied for anxiolytic pathways that modulate GABA receptor gene expression and influence BDNF content without sedation (preclinical|mechanistic).\\n3. **Therefore for you:** If anxiety or neurochemical stress layers compound your nerve damage, Selank is discussed because it targets repair in neurotransmission and neurotrophin pathways — not because it masks symptoms.\\n\\n## How these fit together\\n\\nSingle-compound focus. Selank addresses the anxiety / neurochemistry layer of degeneration. In nerve damage contexts, this may support overall neural environment repair by reducing stress-mediated interference with recovery processes.\\n\\n## What the evidence actually shows\\n\\nHuman data are limited to anxiety disorders. One study of 62 patients with GAD or neurasthenia found Selank produced anxiolytic effects comparable to medazepam (human). Another trial showed 40% rapid responders with significant anxiety score drops in 3 days and 60% gradual responders by day 14 (human). No human trials directly examine nerve damage or neuropathy.\\n\\nPreclinical data include rat studies showing Selank alters expression of 45 neurotransmission genes in frontal cortex within 1 hour, with positive correlation to GABA effects (preclinical). ","tokens_in":18001,"tokens_out":2676,"cost":0,"prev":"genesis","hash":"7c9bebf9bc4915d1112e32e268cf17b25e691725c904cb6b7741f38231cfc575"},{"ts":"2026-07-17T02:41:39.129Z","model":"owner","action":"voxel_divide","prompt":"","input":"selank-nerve-damage","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"7c9bebf9bc4915d1112e32e268cf17b25e691725c904cb6b7741f38231cfc575","hash":"15adbe07115565d67e68ee05b7fa2185ca2ab6e09a351b6ac260e37645cee541"}]}